Bintai Kinden ties up with Scientillence


“Bintai Healthcare and Scientillence will work together to explore and identify suitable new markets to expand and distribute Scientillence’s products and other products in the private and commercial sector such as non-governmental organisations,” said Bintai Kinden executive director Azri Azerai.

PETALING JAYA: Bintai Kinden Corp Bhd is teaming up with Scientillence Sdn Bhd for hemodialysis-related businesses in South-East Asia.

In a statement, the group said its subsidiary Bintai Healthcare Sdn Bhd had inked a collaborative agreement with Scientillence to jointly develop and market medical products in the hemodialysis market.

They will also develop, invest, acquire or own dialysis centres and other related renal care businesses in Malaysia and South-East Asia.

Scientillence, owned by the former CEO and chairman of hospital group Pantai Holdings Bhd Tan Sri Lim Tong Yong, is the sole manufacturer of dialyser (artificial kidney) in Malaysia as well as South-East Asia.

Currently, Scientillence’s products are exported mainly to China, India, Pakistan, Bangladesh, Saudi Arabia, Turkey, Lebanon and most of the South-East Asian countries.

Scientillence Sdn Bhd lab testing equipment for contamination. (File pic)Scientillence Sdn Bhd lab testing equipment for contamination. (File pic)

“Bintai Healthcare and Scientillence will work together to explore and identify suitable new markets to expand and distribute Scientillence’s products and other products in the private and commercial sector such as non-governmental organisations,” said Bintai Kinden executive director Azri Azerai.

Meanwhile, Scientillence as the manufacturer of the hemodialyser in Malaysia and South-East Asia will be providing all the necessary technical support and services in relation to the marketing and selling of the products.

Bintai Healthcare is registered with Medical Device Authority as an authorised representative, distributor and importer of medical devices in Malaysia.

Bintai Kinden said the collaboration is expected to contribute positively towards the group’s future earnings.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Bintai Kinden , Scientillence , dialysis , Azri Azerai ,

   

Next In Business News

US and UK should be welcoming talent, not driving it away
Short Position: Ringgit rebound, PETRONAS earnings
KWAP seeks stronger income growth
What’s in fashion
Brexiteers, no one wants your regulatory bonfire
EcoWorld redefines concept behind industrial parks
S’pore chips away at HK’s hedge fund dominance
Ringgit seen strengthening further
Hibiscus gets debt boost
Navigating a ‘perfect positive storm’

Others Also Read